Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;130(1 Pt 1):20-4.

[Frequency, severity and treatment of ocular rosacea during cutaneous rosacea]

[Article in French]
Affiliations
  • PMID: 12605152
Free article

[Frequency, severity and treatment of ocular rosacea during cutaneous rosacea]

[Article in French]
J-L Michel et al. Ann Dermatol Venereol. 2003 Jan.
Free article

Abstract

Introduction: We have tried to assess the incidence and disclosing factors of ocular rosacea and its treatment in patients presenting with cutaneous rosacea.

Patients and methods: We conducted a prospective study over two years of all the patients consulting the Dermatology department of the University hospital in Saint-Etienne for cutaneous rosacea, and signs of the ocular form using a questionnaire and clinical examination. Each patient's case report was then studied individually when the patient presented signs of ocular rosacea.

Results: Three hundred eighteen patients consulted for cutaneous rosacea. Only 19 patients (6%) exhibited an ocular rosacea. Erythrocouperose was the predominant cutaneous stage. Conjunctivitis and keratitis were the predominating ophthalmologic symptoms. Tetracyclines were the treatment generally used with 72% of good response. Among the patients presenting with ocular rosacea, 52% had been referred by their general practitioner.

Discussion: The severity of the ocular damage is not correlated with the stage of cutaneous involvement. Ocular rosacea in its most developed form still remains the domain of the ophthalmologist. This study confirms cyclines as the treatment of choice in this disease.

PubMed Disclaimer

Publication types

LinkOut - more resources